Ginkgo Bioworks Holdings, Inc.

NYSE DNA

Ginkgo Bioworks Holdings, Inc. Market Capitalization on January 14, 2025: USD 492.02 M

Ginkgo Bioworks Holdings, Inc. Market Capitalization is USD 492.02 M on January 14, 2025, a -81.71% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Ginkgo Bioworks Holdings, Inc. 52-week high Market Capitalization is USD 3.42 B on February 15, 2024, which is 594.79% above the current Market Capitalization.
  • Ginkgo Bioworks Holdings, Inc. 52-week low Market Capitalization is USD 302.96 M on September 09, 2024, which is -38.43% below the current Market Capitalization.
  • Ginkgo Bioworks Holdings, Inc. average Market Capitalization for the last 52 weeks is USD 1.29 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
NYSE: DNA

Ginkgo Bioworks Holdings, Inc.

CEO Dr. Jason Kelly Ph.D.
IPO Date April 19, 2021
Location United States
Headquarters 27 Drydock Avenue
Employees 1,218
Sector Health Care
Industries
Biotechnology
Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

StockViz Staff

January 15, 2025

Any question? Send us an email